A Survey of the FDA’s Adverse Event Reporting System Database Concerning Urogenital Tract Infections and Sodium Glucose Cotransporter‐2 Inhibitor Use
Diabetes Therapy - United States
doi 10.1007/s13300-019-0611-9
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2019
Authors
Publisher
Springer Science and Business Media LLC